Details of the Drug
General Information of Drug (ID: DMTUHFX)
Drug Name |
D-Phenylalanine
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
D-phenylalanine; 673-06-3; H-D-Phe-OH; (2R)-2-amino-3-phenylpropanoic acid; Sabiden; Phenylalanine D-form; D-Phe; (R)-2-AMINO-3-PHENYLPROPANOIC ACID; Alanine, phenyl-, D-; NCI-C60195; UNII-032K16VRCU; (R)-2-Amino-3-phenylpropionic acid; D-alpha-Amino-beta-phenylpropionic acid; CCRIS 6267; EINECS 211-603-5; NSC 25005; 032K16VRCU; CHEBI:16998; COLNVLDHVKWLRT-MRVPVSSYSA-N; MFCD00004270; D-Phenylalanine, 99+%; d-phenylalanin; D-.beta.-Phenylalanine; Phenylalanine,d-; DPhe; l-3-phenylalanine; HDPheOH; (D)-Phenylalanine; Phenylalanine,(S)
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 165.19 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | -1.5 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
References